These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 971653)

  • 1. Drug discontinuation among long term, successfully maintained schizophrenic outpatients.
    Hogarty GE; Ulrich RF; Mussare F; Aristigueta N
    Dis Nerv Syst; 1976 Sep; 37(9):494-500. PubMed ID: 971653
    [No Abstract]   [Full Text] [Related]  

  • 2. Withdrawal symptoms after long-term treatment with low-potency neuroleptics.
    Chouinard G; Bradwejn J; Annable L; Jones BD; Ross-Chouinard A
    J Clin Psychiatry; 1984 Dec; 45(12):500-2. PubMed ID: 6150030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supersensitivity psychosis.
    Peet M
    J Clin Psychiatry; 1991 Feb; 52(2):90. PubMed ID: 1671568
    [No Abstract]   [Full Text] [Related]  

  • 4. A double-blind comparison of pimozide and chlorpromazine in the maintenance care of chronic schizophrenic outpatients.
    Kolivakis T; Azim H; Kingstone E
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):998-1004. PubMed ID: 4214674
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical effects of various schedules of medication.
    Chien CP; DiMascio A
    Behav Neuropsychiatry; 1971; 3(1):5-9. PubMed ID: 5566336
    [No Abstract]   [Full Text] [Related]  

  • 6. Approaches to the problem of preventing hazards of long-term neuroleptic treatment and of avoiding unnecessary drugs.
    Kristjansen P
    Adv Biochem Psychopharmacol; 1980; 24():505-11. PubMed ID: 6105796
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lack of involuntary abnormal movements in untreated schizophrenic patients].
    Hernán Silva I; Jerez CS; Ruiz TA; Seguel LM; Court LJ; Labarca BR
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1994; 22(5):200-2. PubMed ID: 7817846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [What should we recommend for schizophrenic patients: long-term drug prevention or interval treatment?].
    Müller P
    Nervenarzt; 1983 Sep; 54(9):477-85. PubMed ID: 6138720
    [No Abstract]   [Full Text] [Related]  

  • 9. Antipsychotic medication: clinical guidelines for maintenance therapy.
    Johnson DA
    J Clin Psychiatry; 1985 May; 46(5 Pt 2):6-15. PubMed ID: 2859281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic-withdrawal akathisia versus antipsychotic-induced akathisia: further evidence for the existence of tardive akathisia.
    Dufresne RL; Wagner RL
    J Clin Psychiatry; 1988 Nov; 49(11):435-8. PubMed ID: 2903141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressive symptoms in chronic schizophrenic patients after withdrawal of long-acting neuroleptics.
    Wistedt B; Palmstierna T
    J Clin Psychiatry; 1983 Oct; 44(10):369-71. PubMed ID: 6643398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of withdrawal of typical and atypical antipsychotic drugs: a case study.
    Alphs LD; Lee HS
    J Clin Psychiatry; 1991 Aug; 52(8):346-8. PubMed ID: 1869497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Discontinuation of neuroleptic treatment in patients with schizophrenia].
    Alagille M; Blondiaux I; Ginestet D
    Encephale; 1990; 16(2):125-31. PubMed ID: 1972052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled trial of phenothiazine withdrawal in chronic schizophrenic patients.
    Andrews P; Hall JN; Snaith RP
    Br J Psychiatry; 1976 May; 128():451-5. PubMed ID: 776312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic-induced supersensitivity psychosis: retrospective study of schizophrenic inpatients.
    Hunt JI; Singh H; Simpson GM
    J Clin Psychiatry; 1988 Jul; 49(7):258-61. PubMed ID: 2899071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Modification of long-term schizophrenia by somato-therapeutic measures].
    Gross G; Huber G; Schüttler R
    Psychiatr Clin (Basel); 1980; 13(3-4):179-92. PubMed ID: 6113621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management strategies for the treatment of schizophrenia.
    Kane JM
    J Clin Psychiatry; 1999; 60 Suppl 12():13-7. PubMed ID: 10372604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lateralized deficits and drug influences on the dichotic listening of schizophrenic patients.
    Gruzelier JH; Hammond NV
    Biol Psychiatry; 1980 Oct; 15(5):759-79. PubMed ID: 7417630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes.
    O'Croinin F; Zibin T
    J Psychiatry Neurosci; 1994 May; 19(3):226. PubMed ID: 8031748
    [No Abstract]   [Full Text] [Related]  

  • 20. [Complete neuroleptic withdrawal in patients with schizophrenia with intense symptoms and resistant to treatment].
    Wolf MA; Bailly L; Diener JM; Martinet JP; Peretti S; Garneau Y
    Encephale; 1991; 17(4):255-61. PubMed ID: 1683626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.